β-blockers in congenital short-QT syndrome as ion channel blockers

J Cardiovasc Electrophysiol. 2013 Oct;24(10):1172-4. doi: 10.1111/jce.12204. Epub 2013 Jul 25.
No abstract available

Keywords: cardiac channelopathies; carvedilol; long-QT syndrome; metoprolol; potassium channels; short-QT syndrome; β-blockers.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology*
  • Animals
  • Arrhythmias, Cardiac / metabolism*
  • Carbazoles / pharmacology*
  • Ether-A-Go-Go Potassium Channels / antagonists & inhibitors*
  • Heart Conduction System / abnormalities*
  • Heart Defects, Congenital / metabolism*
  • Humans
  • KCNQ1 Potassium Channel / antagonists & inhibitors*
  • Metoprolol / pharmacology*
  • Mutation*
  • Potassium Channel Blockers / pharmacology*
  • Propanolamines / pharmacology*

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Ether-A-Go-Go Potassium Channels
  • KCNQ1 Potassium Channel
  • Potassium Channel Blockers
  • Propanolamines
  • Metoprolol